“Or we wait for Brazil trial results and get an
Post# of 148155
We need a significant trial with a P value under 0.05 and the only place that is happening is Brazil.
“Not even factoring in the potential of LH.”
The LH trial is phase 2, with 50 people (25 on LL), which is too early/small to swing the market.
“Ask yourself why so many are out there shit-talking the company.”
There are two components to the company - the molecule and the management. What I see in the public discourse is a strong belief in the molecule and and frustration with management.
Read More: https://investorshangout.com/post/newpost/605...z6v8ZZeQIJ